許 惠晴

Medicine & Life Sciences

1. Autoimmune Diseases 100%
2. Sjogren's Syndrome 77%
3. Cohort Studies 69%
4. Rheumatoid Arthritis 50%
5. Population 50%
6. Hepacivirus 42%
7. Appendectomy 41%
8. Virus Diseases 36%
9. Thyroiditis 35%
10. Bisphosphonate-Associated Osteonecrosis of the Jaw 34%
11. Gouty Arthritis 34%
12. Thymectomy 29%
13. Pneumocystis Pneumonia 28%
14. Hip Replacement Arthroplasties 27%
15. Atrioventricular Block 27%
16. Histamine Antagonists 26%
17. Comorbidity 26%
18. Proton Pump Inhibitors 26%
19. Allergic Rhinitis 25%
20. Autoimmune Haemolytic Anaemia 25%
21. National Health Programs 25%
22. Osteomyelitis 25%
23. Taiwan 24%
24. Rheumatic Diseases 24%
25. Chronic Hepatitis C 24%
26. Proportional Hazards Models 23%
27. Knee Replacement Arthroplasties 23%
28. Biological Products 22%
29. Systemic Lupus Erythematosus 22%
30. Hepatitis B virus 22%
31. Interferons 21%
32. Arthritis 20%
33. Parkinson Disease 19%
34. Dementia 19%
35. Hepatocellular Carcinoma 18%
36. Antibodies 16%
37. Systemic Vasculitis 16%
38. Ankylosing Spondylitis 15%
39. Tonsillectomy 14%
40. Addison Disease 13%
41. Databases 13%
42. Myasthenia Gravis 12%
43. Hashimoto Disease 12%
44. Graves Disease 12%
45. Confidence Intervals 12%
46. Infections 10%
47. Retrospective Studies 10%
48. Membranous Glomerulonephritis 9%
49. Dysbiosis 9%
50. Multivariate Analysis 9%